GSK plc Files Share Transaction Report (6-K)
Ticker: GSK · Form: 6-K · Filed: Apr 20, 2026 · CIK: 0001131399
Sentiment: neutral
Topics: share-transaction, 6-k
TL;DR
GSK bought/sold its own shares, filing 6-K on 4/20/26.
AI Summary
On April 20, 2026, GSK plc filed a Form 6-K with the SEC, reporting a transaction involving its own shares. The filing, with SEC Accession No. 0001654954-26-003688, was accepted on the same date. The company's mailing and business address is 79 New Oxford Street, London, WC1A 1DG, United Kingdom.
Why It Matters
This filing indicates GSK plc is actively managing its own share capital, which can impact share price and investor perception.
Risk Assessment
Risk Level: low — This is a routine filing about share transactions and does not indicate significant new risks.
Key Players & Entities
- GSK plc (company) — Filer
- 0001131399 (company) — CIK number for GSK plc
- 0001654954-26-003688 (filing_id) — SEC Accession Number
- 2026-04-20 (date) — Filing Date and Period of Report
- 79 NEW OXFORD STREET LONDON United Kingdom WC1A 1DG (address) — Mailing and Business Address
FAQ
What specific type of transaction involving its own shares did GSK plc report?
The filing is titled 'TRANSACTION IN OWN SHARES', indicating GSK plc engaged in a transaction involving its own shares.
When was this Form 6-K filing accepted by the SEC?
The filing was accepted on April 20, 2026.
What is GSK plc's CIK number?
GSK plc's CIK number is 0001131399.
Where is GSK plc's business address located?
GSK plc's business address is 79 New Oxford Street, London, United Kingdom WC1A 1DG.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001654954-26-003688.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 20, 2026 regarding GSK plc (GSK).